OncoLink

Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate

Lawton CA, Winter K, Murray K, et al.
Abramson Cancer Center of the University of Pennsylvania